Mark C. Leavitt

1.0k total citations
28 papers, 812 citations indexed

About

Mark C. Leavitt is a scholar working on Molecular Biology, Oncology and Virology. According to data from OpenAlex, Mark C. Leavitt has authored 28 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Virology. Recurrent topics in Mark C. Leavitt's work include RNA and protein synthesis mechanisms (10 papers), HIV Research and Treatment (5 papers) and Viral-associated cancers and disorders (4 papers). Mark C. Leavitt is often cited by papers focused on RNA and protein synthesis mechanisms (10 papers), HIV Research and Treatment (5 papers) and Viral-associated cancers and disorders (4 papers). Mark C. Leavitt collaborates with scholars based in United States and United Kingdom. Mark C. Leavitt's co-authors include Junetsu Ito, Flossie Wong‐Staal, Guhung Jung, Osamu Yamada, Mang Yu, Jack R. Barber, Peter J. Welch, G Kraus, Jen‐Chuen Hsieh and Eric M. Poeschla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Virology.

In The Last Decade

Mark C. Leavitt

27 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C. Leavitt United States 16 583 204 193 127 123 28 812
Stuart Le Grice United States 9 755 1.3× 216 1.1× 106 0.5× 56 0.4× 55 0.4× 11 941
Bruno Sargueil France 20 1.0k 1.7× 166 0.8× 71 0.4× 68 0.5× 43 0.3× 46 1.2k
Benjamin Rovinski Canada 14 442 0.8× 329 1.6× 131 0.7× 50 0.4× 120 1.0× 22 843
Richard Tritz United States 11 764 1.3× 70 0.3× 93 0.5× 114 0.9× 46 0.4× 14 859
Mary K. Short United States 13 330 0.6× 176 0.9× 119 0.6× 21 0.2× 123 1.0× 24 709
Gregory A. Sowd United States 15 594 1.0× 494 2.4× 75 0.4× 57 0.4× 157 1.3× 21 957
Jörg Enssle Germany 11 511 0.9× 294 1.4× 573 3.0× 47 0.4× 269 2.2× 17 947
Pamela C. Wagaman United States 13 266 0.5× 198 1.0× 136 0.7× 25 0.2× 288 2.3× 14 647
B. Berkhout Netherlands 20 729 1.3× 624 3.1× 77 0.4× 59 0.5× 89 0.7× 24 1.1k
N Moscufo United States 12 282 0.5× 64 0.3× 137 0.7× 34 0.3× 112 0.9× 15 611

Countries citing papers authored by Mark C. Leavitt

Since Specialization
Citations

This map shows the geographic impact of Mark C. Leavitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Leavitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Leavitt more than expected).

Fields of papers citing papers by Mark C. Leavitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Leavitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Leavitt. The network helps show where Mark C. Leavitt may publish in the future.

Co-authorship network of co-authors of Mark C. Leavitt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Leavitt. A scholar is included among the top collaborators of Mark C. Leavitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Leavitt. Mark C. Leavitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vijay, Suresh, Geoff J.M. Parker, Mark C. Leavitt, et al.. (2015). Evaluation of blood–brain barrier integrity and structural abnormalities in MPS IIIB patients using cerebrospinal fluid/serum albumin index (CSF-AI) and multimodal MRI. Molecular Genetics and Metabolism. 114(2). S121–S122.
2.
Thelwall, Peter E., Fiona E. Smith, Mark C. Leavitt, et al.. (2013). Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: Non-invasive identification and treatment monitoring by magnetic resonance. Journal of Hepatology. 59(3). 543–549. 30 indexed citations
3.
4.
Patel, Tarun B., et al.. (2007). Transgenic avian-derived recombinant human interferon-a2b (AVI-005) in healthy subjects: an open-label, single-dose, controlled study. International Journal of Clinical Pharmacology and Therapeutics. 45(3). 161–168. 6 indexed citations
5.
Duarte, E A, Mark C. Leavitt, Osamu Yamada, & Mang Yu. (2003). Hairpin Ribozyme Gene Therapy for AIDS. Humana Press eBooks. 74. 459–468. 3 indexed citations
6.
Welch, Peter J., Eric G. Marcusson, Qi‐Xiang Li, et al.. (2000). Identification and Validation of a Gene Involved in Anchorage-Independent Cell Growth Control Using a Library of Randomized Hairpin Ribozymes. Genomics. 66(3). 274–283. 48 indexed citations
7.
Feng, Yu, Mark C. Leavitt, Richard Tritz, et al.. (2000). Inhibition of CCR5-Dependent HIV-1 Infection by Hairpin Ribozyme Gene Therapy against CC-Chemokine Receptor 5. Virology. 276(2). 271–278. 51 indexed citations
8.
Leavitt, Mark C., et al.. (2000). Inhibition of Interleukin-1β (IL-1β) Production in Human Cells by Ribozymes Against IL-1β and IL-1β Converting Enzyme (ICE). Antisense and Nucleic Acid Drug Development. 10(6). 409–414. 2 indexed citations
9.
Kraus, G, Antonia Radaelli, Randy Talbott, et al.. (1998). Characterization of a Molecular Clone of HIV Type 2 Infectious for Macaca nemestrina. AIDS Research and Human Retroviruses. 14(1). 65–77. 5 indexed citations
10.
Yu, Mang, et al.. (1995). In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1. Virology. 206(1). 381–386. 47 indexed citations
11.
Yu, Mei, Mark C. Leavitt, M Maruyama, et al.. (1995). Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.. Proceedings of the National Academy of Sciences. 92(3). 699–703. 84 indexed citations
12.
Zhu, Wei‐Guo, Mark C. Leavitt, Guhung Jung, & Junetsu Ito. (1994). Mutagenesis of a highly conserved lysine 340 of the PRD1 DNA polymerase. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1219(2). 260–266. 4 indexed citations
13.
Yamada, Osamu, G Kraus, Mark C. Leavitt, Mang Yu, & Flossie Wong‐Staal. (1994). Activity and Cleavage Site Specificity of an Anti-HIV-1 Hairpin Ribozyme in Human T Cells. Virology. 205(1). 121–126. 41 indexed citations
14.
Leavitt, Mark C., Mang Yu, Osamu Yamada, et al.. (1994). Transfer of an Anti-HIV-1 Ribozyme Gene into Primary Human Lymphocytes. Human Gene Therapy. 5(9). 1115–1120. 79 indexed citations
15.
Jung, Guhung, Mark C. Leavitt, Michelle Schultz, & Junetsu Ito. (1990). Site-specific mutagenesis of PRD1 DNA polymerase: Mutations in highly conserved regions of the family B DNA polymerase. Biochemical and Biophysical Research Communications. 170(3). 1294–1300. 17 indexed citations
16.
Jung, Guhung, et al.. (1987). Primary structure of the DNA terminal protein of bacteriophage PRD1. Nucleic Acids Research. 15(21). 8999–9009. 22 indexed citations
17.
Jung, Guhung, Mark C. Leavitt, & Junetsu Ito. (1987). yeast killer plasmid pGKL1 encodes a DNA polymerase belonging to the family B DNA polymerases. Nucleic Acids Research. 15(21). 9088–9088. 40 indexed citations
18.
Jung, Guhung, Mark C. Leavitt, Jen‐Chuen Hsieh, & Junetsu Ito. (1987). Bacteriophage PRD1 DNA polymerase: evolution of DNA polymerases.. Proceedings of the National Academy of Sciences. 84(23). 8287–8291. 79 indexed citations
19.
Leavitt, Mark C. & Junetsu Ito. (1987). Nucleotide sequence ofBacillusphage Nf terminal protein gene. Nucleic Acids Research. 15(13). 5251–5259. 24 indexed citations
20.
Moses, Richard, Barbara Frank-Job, Mark C. Leavitt, & Robert F. Miller. (1986). The Syndrome of Type A Chronic Atrophic Gastritis, Pernicious Anemia, and Multiple Gastric Carcinoids. Journal of Clinical Gastroenterology. 8(1). 61–65. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart Le Grice Breakdown of academic impact, for papers by Bruno Sargueil Breakdown of academic impact, for papers by Benjamin Rovinski Breakdown of academic impact, for papers by Richard Tritz Breakdown of academic impact, for papers by Mary K. Short Breakdown of academic impact, for papers by Gregory A. Sowd Breakdown of academic impact, for papers by Jörg Enssle Breakdown of academic impact, for papers by Pamela C. Wagaman Breakdown of academic impact, for papers by B. Berkhout Breakdown of academic impact, for papers by N Moscufo
Rankless by CCL
2026